Cardiology / Stroke

CHA₂DS₂-VASc Score

Stroke risk stratification in non-valvular atrial fibrillation. Guides anticoagulation decisions with annual stroke risk estimation and includes HAS-BLED bleeding risk assessment.

0
0/9No Anticoagulation
Annual stroke risk: 0%

CHA₂DS₂-VASc Score

0%annual stroke riskLowMedHigh
No Anticoagulation (Score 0/9)

Annual Stroke Risk

0%
0
0%
1
1.3%
2
2.2%
3
3.2%
4
4%
5
6.7%
6
9.8%
7
9.6%
8
6.7%
9
15.2%
Annual adjusted stroke risk by CHA₂DS₂-VASc score

Anticoagulation Recommendation

No anticoagulation needed. Low stroke risk. Reassess periodically if risk factors develop.

No antithrombotic therapy needed. This patient is truly low-risk. Reassess if new risk factors develop (hypertension, diabetes, heart failure, vascular disease, or ageing into a higher bracket).

Based on Lip GYH et al. Chest 2010. Enhanced with clinical pearls by Dr Sumit Mandal.